Sanofi reports setbacks to Denali, Kymab and Principia assets, delivering mix of misses and...

cafead

Administrator
Staff member
  • cafead   Oct 27, 2023 at 11:42: AM
via Sanofi has reported setbacks to a trio of candidates bought in by its business development team, halting work or posting negative data on assets picked up from Denali Therapeutics, Kymab and Principia Biopharma.

article source
 

<